TB

The World Health Organization’s campaign website for World TB Day includes an advocacy and communication toolkit, an animated logo, posters, social media tiles, videos, and other TB-related links to help spread the theme “It’s TIME.”

The webinar provides information on the foundational principles of adult learning theory and shows how the principles can be used in developing trainings.

The False-Positive Investigation Toolkit provides mycobacteriology staff with updated resources to recognize potential false-positive results and to assist in false-positive investigations. The toolkit includes job-aids, posters, and templates that can be modified for local use.

This tool is designed to support the effective monitoring and evaluation (M&E) of tuberculosis (TB) control programs in refugee camps and other settings located in resource-poor areas.

The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.

This guide was developed to help advocacy, communication, and social mobilization (ACSM) programs at national and subnational levels strengthen routine monitoring and evaluation of tuberculosis ACSM activities.

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. For each of the three CDC-recommended LTBI regimens, there is a fact sheet in the series that can be personalized for individual patients. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

This fact sheet describes the impact of HIV-TB co-infection. It also presents work currently being done to find and treat HIV-TB.

Based on The Union's 93-years of working in the field, the new guide tackles the challenges of fulfilling each patient's potential for cure from both the clinician's and the programme manager's perspective.

These stories highlight the personal experiences of several people who were diagnosed and treated for TB disease, as well as the work of TB control professionals. You can share individual stories on social media using the social media graphics included on several of the survivor story pages.